SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

ESH Acquisition Corp. is a blank check company. It was formed for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses. The company was founded on November 17, 2021 and is headquartered in New York, NY.

ESH Acquisition Corp - Ordinary Shares - Class A

ESH Acquisition Corp (ESHA) is trending amidst a broader "SPAC mania," with community discussion centered on its exceptionally low public float and high insider ownership. Traders are actively comparing it to recent explosive movers like AFJK, believing ESHA's tight share structure positions it for significant, rapid gains. This setup is fueling speculative interest and discussions around its potential for sharp upward price action.

Vanda Pharmaceuticals, Inc. engages in the development and commercialization of therapies for high unmet medical needs. The firm intends to treat schizophrenia, jet lag disorder, atopic dermatitis, central nervous system disorders, and circadian rhythm sleep disorder. Its product portfolio includes HETLIOZ, Fanapt, Tradipitant, Trichostatin, and AQW051. The company was founded by Mihael Hristos Polymeropoulos and Argeris N. Karabelas in 2002 and is headquartered in Washington, DC.

Vanda Pharmaceuticals Inc

Vanda Pharmaceuticals (VNDA) is trending due to the FDA approval of NEREUS, which marks the first new pharmacologic treatment for motion sickness in over four decades and is seen by many as significantly under-modeled by the market. The community is actively discussing its potential for off-label use in addressing GLP-1 induced nausea, positioning it as a major upside driver with billions in market potential and fueling significant speculation about a potential buyout from a larger GL-1 focused pharmaceutical company. This approval, coupled with other pipeline catalysts, signals a significant re-rating opportunity for VNDA as it transitions into a commercial-stage company.

Corcept Therapeutics, Inc. is a commercial-stage pharmaceutical company, which engages in the business of discovering and developing pharmaceutical products and medications to treat severe endocrinologic, oncologic, metabolic, and neurologic disorders by modulating the effects of the hormone cortisol. The company was founded by David B. Singer and Joseph K. Belanoff on May 13, 1998 and is headquartered in Redwood City, CA.

Corcept Therapeutics Inc

Corcept Therapeutics is trending sharply lower after receiving a Complete Response Letter from the FDA for its relacorilant drug, intended for Cushing's syndrome. The community is actively debating the severe market reaction, with many expressing disappointment and predicting further downside, while others view the significant dip as a potential buying opportunity. This decision casts a shadow on the company's near-term growth strategy and future pipeline utilizing similar mechanisms, prompting discussions around its market valuation relative to existing revenue and competitors.

Webull Corp. engages in the provision of financial services. It offers trading, wealth management product distribution, market data and information, user community, and investor education. The company was founded by An Quan Wang in 2016 and is headquartered in St. Petersburg, FL.

Webull Corp. - Ordinary Shares - Class A

Webull Corp

Webull Corporation (BULL) is actively trending as investors discuss significant year-end tax loss harvesting contributing to recent price declines. Community sentiment is sharply divided, with optimists highlighting the fintech brokerage's profitability, growing user base, and international expansion as a long-term opportunity, while skeptics warn of persistent dilution and fierce competition.

Intelligent Bio Solutions, Inc. is a medical technology company, which engages in delivering testing solutions. It operates through the Intelligent Fingerprinting Products (IFPG) and Saliva Glucose Biosensor Platform (SGBP) segments. It offers biochemistry, immunology, tumor markers, hormones, and nucleic acid diagnostic modalities. The company was founded on December 5, 2016 and is headquartered in New York, NY.

Intelligent Bio Solutions Inc

Intelligent Bio Solutions (INBS) is trending amid news of a new manufacturing partnership aimed at boosting production and margins, coupled with persistent community focus on its ongoing FDA 510(k) clearance process for a non-invasive fingerprint drug screening system. Investors are keenly anticipating the potential for significant upside from U.S. market entry, driven by the technology's innovation and the stock's low float, though concerns around potential dilution and extended FDA timelines continue to spark debate.

Xeris Biopharma Holdings, Inc. is a biopharmaceutical company, which engages in developing and commercializing products across a range of therapies. The company has three commercial products: Gvoke, Keveyis, and Recorlev. Gvoke is ready-to-use liquid glucagon for the treatment of severe hypoglycemia. Keveyis is the therapy approved in the United States to treat hyperkalemic, hypokalemic, and related variants of primary periodic paralysis (PPP). Recorlev is a cortisol synthesis inhibitor approved for the treatment of endogenous hypercortisolemia in adult patients with Cushing’s syndrome. Its product also includes Ogluo which is used for the treatment of severe hypoglycemia in adults, adolescents, and children aged 2 years and over with diabetes mellitus. The company was founded by Steven Prestrelski in 2005 and is headquartered in Chicago, IL.

Xeris Biopharma Holdings Inc

Xeris Biopharma is trending as a key competitor, Corcept Therapeutics, faced an FDA Complete Response Letter for its Cushing's syndrome treatment, effectively clearing the path for Xeris's rapidly growing Recorlev to capture more market share. The community is buzzing with enthusiasm, emphasizing Xeris's strong gross margins, anticipated profitability, and the multi-blockbuster potential of its XP-8121 pipeline, leading to widespread expectations for a significant re-rating by analysts.

Aimei Health Technology Co., Ltd. is a blank check company, which engages in entering a merger, share exchange, asset acquisition, share purchase, recapitalization, reorganization or similar business combination with one or more businesses. The company was founded on April 27, 2023 and is headquartered in New York, NY.

Aimei Health Technology Co Ltd

Aimei Health Technology ($AFJK) is currently a prime focus for event-driven traders due to its low float and ongoing speculation around potential business combination news, fueling significant volatility. The community is actively discussing its potential for short squeezes and its resemblance to other recent high-flying SPACs in a speculative market.

Axsome Therapeutics, Inc. is a commercial-stage biopharmaceutical company, which engages in the development of novel therapies for the management of central nervous system disorders. Its portfolio consists of Products Overview and Pipeline Overview. The Products Overview includes Auvelity and Sunosi. The Pipeline Overview refers to AXS-05, AXS-07, AXS-12, and AXS-14. The company was founded by Herriot Tabuteau on January 12, 2012 and is headquartered in New York, NY.

Axsome Therapeutics Inc

Axsome Therapeutics is gaining significant attention following the FDA's acceptance and priority review of its supplemental New Drug Application for AXS-05 for Alzheimer's agitation. This expedited regulatory pathway is sparking considerable investor excitement, with the community highly optimistic about the company's expanding central nervous system pipeline and the continued strong commercial performance of its existing therapies.

TeraWulf, Inc. owns and operates fully integrated environmentally clean bitcoin mining facilities in the United States. TeraWulf will generate domestically produced bitcoin powered by nuclear, hydro and solar energy. The company was founded by Paul Prager and Nazar Khan on February 8, 2021 and is headquartered in Easton, MD.

TeraWulf Inc

TeraWulf (WULF) is trending amidst diverse community sentiment following its successful closing of a $1.3 billion project-level financing for a major AI/HPC data center, an event bulls view as a strong validation of its strategic pivot. While supporters see this and recent zoning approvals as foundational for future growth and a buying opportunity, others express frustration over persistent price weakness, attributing it to broader market volatility and perceived manipulation.

Taiwan Semiconductor Manufacturing Co., Ltd. engages in the manufacture and sale of integrated circuits and wafer semiconductor devices. Its chips are used in personal computers and peripheral products, information applications, wired and wireless communications systems products, and automotive and industrial equipment including consumer electronics such as digital video compact disc player, digital television, game consoles, and digital cameras. The company was founded by Chung Mou Chang on February 21, 1987 and is headquartered in Hsinchu, Taiwan.

Taiwan Semiconductor Manufacturing - ADR

Taiwan Semiconductor is trending as reports indicate Nvidia is seeking to significantly ramp up H200 AI chip production with TSMC to meet robust demand from Chinese technology companies. This news highlights TSMC's critical role as the foundational supplier for leading AI chipmakers, driving positive sentiment among investors discussing its expanding capacity and strong institutional support.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Best Blockchain Stocks Worth Watching - December 19th

Core Scientific, Globant, Argo Blockchain plc 8.75% Senior Notes due 2026, Figure Technology Solutions, and Bitdeer Technologies Group are the five Blockchain stocks to watch today, according to...

Best Blockchain Stocks Worth Watching - December 17th

Core Scientific, Argo Blockchain plc 8.75% Senior Notes due 2026, Globant, Figure Technology Solutions, and Bitdeer Technologies Group are the five Blockchain stocks to watch today, according to...

Top Blockchain Stocks To Follow Now - December 16th

Core Scientific, Bitdeer Technologies Group, and Argo Blockchain plc 8.75% Senior Notes due 2026 are the three Blockchain stocks to watch today, according to MarketBeat's stock screener tool...

Top Blockchain Stocks To Keep An Eye On - December 13th

Core Scientific, Figure Technology Solutions, Globant, Bitdeer Technologies Group, and Argo Blockchain plc 8.75% Senior Notes due 2026 are the five Blockchain stocks to watch today, according to...

Promising Blockchain Stocks To Watch Now - December 12th

Core Scientific, Figure Technology Solutions, Globant, Argo Blockchain plc 8.75% Senior Notes due 2026, Bitdeer Technologies Group, Mawson Infrastructure Group, and Digi Power X are the seven...

Argo Blockchain (NASDAQ:ARBK) Reaches New 12-Month Low - Here's What Happened

Argo Blockchain (NASDAQ:ARBK) Reaches New 12-Month Low - Should You Sell...

Argo Blockchain (ARBK) shares surged more than 30% in mid-day trading Monday after the Bitcoin miner announced it had entered into a non-binding term sheet for up to $40 million in senior secured convertible loans.The company said the capital infusion would be used to upgrade its mining fleet at its Baie-Comeau facility in Quebec, bolster its balance sheet, and evaluate merger and acquisition opportunities.Under the proposed deal, an initial tranche of $15 million would be disbursed, with additional funding of up to $25 million available over the next 18 months. The debt financing carries an interest rate of approximately 8%.Argo said the financing is expected to come from up to three multinational institutional investors and will include 30% warrant coverage at a premium to the closing price.As part of the agreement, Argo has granted the investor group a 20-day exclusivity period, with potential extensions depending on progress. The company also agreed to a $150,000 break fee under certain conditions.<figure class="image"><img style="aspect-ratio:1295/285;" src="https://st-everywhere-cms-prod.s3.us-east-1.amazonaws.com/Screenshot_2025_03_03_125636_5087bc0946.png" alt="Screenshot 2025-03-03 125636.png" width="1295" height="285"><figcaption>Argo Blockchain retail sentiment and message volume on March 3 as of 12:55 p.m. ET | Source: Stocktwits</figcaption></figure>Retail sentiment on Stocktwits around&nbsp;<a href="https://stocktwits.com/symbol/ARBK">Argo’s stock</a> surged into the ‘extremely bullish’ zone from ‘neutral’ a day ago, as chatter jumped to ‘extremely high’ from ‘extremely low’ levels. Some investors took the opportunity to cash in on the rally.<stembedurl>https://stocktwits.com/josg82/message/606516750</stembedurl>Despite the stock's sudden spike, it remains down 13% year-to-date and has lost more than 77% over the past year.Argo Blockchain has recently undergone a change in its management. Former CEO Thomas Chippas stepped down on&nbsp;Feb. 28.Moreover, the company received a Nasdaq delisting warning in January due to its prolonged stock price decline.For updates and corrections, email newsroom[at]stocktwits[dot]com.Read also:&nbsp;<a href="https://stocktwits.com/news-articles/markets/equity/tsmc-stock-slides-4-month-low-despite-100-billion-chip-expansion-plan/che0No9Rzy">TSMC Stock Slides To 4-Month Low Even As Trump Reportedly Plans To Announce $100B US Chip Deal – Retail Remains Bullish</a>

Representative image of Bitcoin mining servers. (Photo by Jason Marz/Getty Images)

Argo Blockchain Stock Rallies On Potential $40 Million Investment To Upgrade Bitcoin Mining Fleet – Retail Sentiment Bullish

Under the proposed deal, an initial tranche of $15 million would be disbursed, with additional funding of up to $25 million available over the next 18 months.

Equity

Argo Blockchain Plc operates as a blockchain technology company focused on large-scale mining of Bitcoin and other cryptocurrencies. It mines using purpose-built computers to solve cryptographic algorithms in the blockchain in exchange for rewards and fees denominated in the native token of that blockchain network. The company was founded in 2017 and is headquartered in London, the United Kingdom.

ARBK
Argo Blockchain Plc

Feed

News

Sentiment

Fundamentals

Info

Latest ARBK News

ARBKArgo Blockchain Plc